UK markets closed
  • NIKKEI 225

    23,474.27
    -165.19 (-0.70%)
     
  • HANG SENG

    24,786.13
    +31.71 (+0.13%)
     
  • CRUDE OIL

    40.61
    +0.58 (+1.45%)
     
  • GOLD FUTURES

    1,905.80
    -23.70 (-1.23%)
     
  • DOW

    28,413.75
    +202.93 (+0.72%)
     
  • BTC-GBP

    9,969.47
    +1,547.88 (+18.38%)
     
  • CMC Crypto 200

    263.24
    +7.14 (+2.79%)
     
  • ^IXIC

    11,521.41
    +36.71 (+0.32%)
     
  • ^FTAS

    3,268.54
    +7.53 (+0.23%)
     

The global market for Nerve Repair and Regeneration is projected to reach US$12.7 billion by 2025

ReportLinker
·25-min read

driven by high incidence of brain disorders and nerve injuries. The human nervous system comprises complex, delicate structures such as the spinal cord, the brain, and peripheral nerves, which are susceptible to different types of injuries.

New York, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Devices Industry" - https://www.reportlinker.com/p05957490/?utm_source=GNW
Nerves constitute the most significant cable systems in the human body, performing the crucial job of carrying messages and information to brain and also to other parts of body. Whenever such critical nerves are injured, problems arise in muscles leading to sensation loss. Major types of nerve injuries include Neuropraxia, the physiologic blocking of nerve; Axonotmesis, the anatomic disruption of axon with slight disruption of connective tissue; and Neurotmesis, the anatomic disruption of connective tissue and nerve fibers.These injuries could result in trauma or more serious neurodegenerative diseases such as Parkinson`s disease, Alzheimer`s disease, multiple system atrophy, multiple sclerosis, and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig`s disease).Alzheimer`s, Parkinson`s, Amyotrophic Lateral Sclerosis and multiple sclerosis are diseases that cause injury to the complex, delicate structures of the nervous system.Till date spinal cord injury and peripheral nerve damage are often permanent and incapacitating.

Innovative strategies are required for a shift in the paradigm and advanced treatment of these neurological injuries.But the question as to whether adult neurogenesis isrealstill remains unanswered with several contentious research studies still underway with no definitive answer to this century-long debate. Regrowth or repair of nervous tissues and cells involves generation of new neurons, glia, axons, myelin, or synapses.Gene Therapy is attracting immense research investments for its promise in promoting nerve regeneration and intraneural revascularization is being studied for its role in peripheral nerve regeneration.Newer studies are however dampening hopes by stating that adults produce no new cells in the hippocampus. Nevertheless, hopes of regeneration arecreating lucrative commercial opportunities as the pressure builds for newer and more effective treatment for neurological diseases.As the world awaits for a paradigm-shift in the treatment of neurological injury, neurostimulation and neuromodulation devices and biomaterials remains a massive multi
billiondollar market worldwide. Neurostimulation and neuromodulation devices are currently available solutions to treat a variety of nerve injuries including peripheral nerve injuries. Neurostimulation and neuromodulation methods involve use of specially designed devices to transmit electrical impulses for controlling activity of the central nervous system and the brain.Internal neurostimulation and neuromodulation devices are growing in popularity for their significantly lower risk for post-surgical complications and shorter hospital stays. These include deep brain stimulation (DBS)for Parkinson`s, epilepsy and depression; spinal cord stimulation (SCS) for pain management and spasticity; gastric electrical stimulation (GES) for obesity and gastroparesis; vagus nerve stimulation (VNS) for depression and epilepsy; and sacral nerve stimulation (SNS) for constipation and urinary incontinence disorders.External neurostimulation devices, on the other hand, comprise transcutaneous vagus nerve stimulation (TVNS) for autism, depression, anxiety and age related disorders; transcutaneous electrical nerve stimulation (TENS)for chronic neuropathic pain and fibromyalgia disorders; transcranial magnetic stimulation (TMS)for depression and ADHD; and respiratory electrical stimulation (RES) for improving the respiratory function after spinal cord injury.


Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW
Nerve Repair and Regeneration Market Set for a Rapid Growth
Neurostimulation and Neuromodulation Devices: Largest Product
Segment
Biomaterials to Exhibit Rapid Growth
Nerve Repair and Regeneration Market by Application
US and Europe Dominate the Market, Asia-Pacific to Register the
Fastest Growth

2. FOCUS ON SELECT PLAYERS
Abbott Laboratories, Inc. (USA)
AxoGen, Inc. (USA)
Boston Scientific Corporation (USA)
Integra LifeSciences Corporation (USA)
LivaNova, PLC (UK)
Medtronic plc (USA)
NeuroPace, Inc. (USA)
Nevro Corporation.(USA)
Orthomed S.A.S. (France)
Polyganics B.V. (The Netherlands)
Stryker Corporation (U.S.)
Synapse Biomedical Inc. (U.S.)

3. MARKET TRENDS & DRIVERS
High Incidence of Brain Disorders and Nerve Injuries: Primary
Market Driver
Annual Incidence of Adult-Onset Neurologic Disorders in the US
Symptomatic Epilepsy Incidence by Type (2019): Percentage Share
Breakdown of Congenital, Degenerative, Infective, Neoplastic,
Trauma, and Vascular Epilepsy
Global Alzheimer’s Prevalence by Age Group
Diagnosed Prevalence Cases of Parkinson?s Disease Across Select
Countries
Classification of Nerve Injuries
Recent Developments in Spinal Cord Injury Treatment
Rising Geriatric Population and Subsequent Growth in Prevalence
Of Neurological Disorders
Global Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Intensified Research Activity Across Various Neural Disciplines
Induces Additional Optimism
Stem Cell Therapy: A Promising Avenue for Nerve Repair and
Regeneration
New Biomaterials Pave the Way for Innovative Neurodegeneration
Therapies
Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
Innovative Nerve Conduits from Stryker
Technological Advancements and Product Innovations - A Key
Growth Driver
Neurostimulation Allows Paralyzed People to Regain Leg Movement
Neurostimulator to Treat Neurological Conditions
Micro-Implantable Solution for Neurostimulation
Parasym? Device for Neurostimulation
Boston Scientific?s Spinal Cord Stimulation Improves Quality of
Life
Intellis? Platform Presents Smallest Implantable Neurostimulator
Innovation in Deep Brain Stimulation for Parkinson?s Disease
Innovations in Spinal Cord Stimulation for Pain
Smart Neuromodulation: The Combination of AI and
Neuromodulation Technologies
New Dynamic Lead Interface Design for Neurostimulator Devices
Wireless SCS Neuromodulation Therapy: An Alternative to
Traditional SCS System
Select Recent Approvals of Neuro-stimulation and
Neuromodulation Devices
Select Launches in Spinal Cord Stimulation (SCS) Market
Select Launches in Deep Brain Stimulation (DBS) Market
Select Neurostimulation Devices in Clinical Trials
Select Neuromodulation Devices in Clinical Trials

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Nerve Repair and
Regeneration Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2020 through 2027

Table 2: World Historic Review for Nerve Repair and
Regeneration Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2019

Table 3: World 15-Year Perspective for Nerve Repair and
Regeneration Devices by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Neurostimulation &
Neuromodulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2020 through 2027

Table 5: World Historic Review for Neurostimulation &
Neuromodulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2019

Table 6: World 15-Year Perspective for Neurostimulation &
Neuromodulation Devices by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Biomaterials by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 8: World Historic Review for Biomaterials by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 9: World 15-Year Perspective for Biomaterials by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2020 through 2027

Table 11: World Historic Review for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2019

Table 12: World 15-Year Perspective for Neurostimulation &
Neuromodulation Surgeries by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Neurorrhaphy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 14: World Historic Review for Neurorrhaphy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 15: World 15-Year Perspective for Neurorrhaphy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Nerve Grafting by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 17: World Historic Review for Nerve Grafting by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 18: World 15-Year Perspective for Nerve Grafting by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Stem Cell Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 20: World Historic Review for Stem Cell Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 21: World 15-Year Perspective for Stem Cell Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 23: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 24: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Ambulatory
Surgery Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2020 through 2027

Table 26: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 27: World 15-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 29: USA Historic Review for Nerve Repair and Regeneration
Devices by Product - Neurostimulation & Neuromodulation Devices
and Biomaterials Markets - Independent Analysis of Annual Sales
in US$ Billion for Years 2012 through 2019

Table 30: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 32: USA Historic Review for Nerve Repair and Regeneration
Devices by Application - Neurostimulation & Neuromodulation
Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 33: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 35: USA Historic Review for Nerve Repair and Regeneration
Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery
Centers Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 38: Canada Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 39: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 41: Canada Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 42: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 44: Canada Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 45: Canada 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 47: Japan Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 48: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 50: Japan Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 51: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 53: Japan Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 54: Japan 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 56: China Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 57: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 59: China Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 60: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 62: China Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 63: China 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 65: Europe Historic Review for Nerve Repair and
Regeneration Devices by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 66: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 68: Europe Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 69: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 71: Europe Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 72: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 74: Europe Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 75: Europe 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 77: France Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 78: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 80: France Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 81: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 83: France Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 84: France 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 86: Germany Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 87: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 89: Germany Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 90: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Nerve Repair
and Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 92: Germany Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 93: Germany 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 95: Italy Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 96: Italy 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 98: Italy Historic Review for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 99: Italy 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 101: Italy Historic Review for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 102: Italy 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 104: UK Historic Review for Nerve Repair and Regeneration
Devices by Product - Neurostimulation & Neuromodulation Devices
and Biomaterials Markets - Independent Analysis of Annual Sales
in US$ Billion for Years 2012 through 2019

Table 105: UK 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &
Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and
Stem Cell Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 107: UK Historic Review for Nerve Repair and Regeneration
Devices by Application - Neurostimulation & Neuromodulation
Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 108: UK 15-Year Perspective for Nerve Repair and
Regeneration Devices by Application - Percentage Breakdown of
Value Sales for Neurostimulation & Neuromodulation Surgeries,
Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the
Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Nerve Repair and
Regeneration Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgery Centers - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 110: UK Historic Review for Nerve Repair and Regeneration
Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery
Centers Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2019

Table 111: UK 15-Year Perspective for Nerve Repair and
Regeneration Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgery Centers
for the Years 2012, 2020 & 2027

SPAIN
Table 112: Spain Current & Future Analysis for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 113: Spain Historic Review for Nerve Repair and
Regeneration Devices by Product - Neurostimulation &
Neuromodulation Devices and Biomaterials Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 114: Spain 15-Year Perspective for Nerve Repair and
Regeneration Devices by Product - Percentage Breakdown of Value
Sales for Neurostimulation & Neuromodulation Devices and
Biomaterials for the Years 2012, 2020 & 2027

Table 115: Spain Current & Future Analysis for Nerve Repair and
Regeneration Devices by Application - Neurostimulation &

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001